Aesthetics BioMedical
- Company typePrivate
- Founded2016
- HeadquartersPhoenix, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
Aesthetics BioMedical firmographics
Firmographics- Name
- Aesthetics BioMedical
- Legal name
- Aesthetics Biomedical, Inc.
- Website
- https://aestheticsbiomedical.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Aesthetics BioMedical industry classification
Industry- Product category
- Aesthetic Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Medical Equipment and Supplies Manufacturing (33911)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Skincare Devices & Beauty Tech (LED, Microcurrent, Cleansing Devices) (CRABAAAJ)
- akta.pro secondary industries
- Dermocosmetics & Medical-Grade Skincare (CRABAAAF), Cosmetic Dermatology (Aesthetic Injectables) (HLAKACAE)
Keywords
Where Aesthetics BioMedical is headquartered
LocationHeadquarters
- HQ city
- Phoenix
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Aesthetics BioMedical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
Revenue model
- Medical Device Sales: Sale of aesthetic devices including UltraVision RF Microneedling systems, Vivace Ultra, Vivace Microneedle RF, Reverso RF, CryoTouch MD, and Elite NS to medical practitioners and aesthetic practices. Devices are FDA-cleared and sold directly through sales team with financing options available through DART.
- Consumable Products: Recurring sales of consumable products including needle sets/tips, Vivace Experience Kits (Soothe Mask and Boost Serum), and SoME Skincare to existing device customers. These create recurring revenue streams from the installed base of devices.
- Skincare Products: Sale of proprietary skincare products including SoME Skincare (autologous topical product), CryoTouch MD, and other skincare solutions. Products sold through their e-commerce platform and through provider network.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Device financing through DART |
Go-to-market motion3 records
Distribution channels3 records
Marketing channels7 records
Aesthetics BioMedical product offering
Product offeringCore offering
Aesthetics BioMedical develops and manufactures FDA-cleared aesthetic medical devices, centered on its proprietary combination of ultrasound imaging and uniform radiofrequency (RF) microneedling technology. The company sells these devices directly to medical aesthetic practices, dermatology clinics, plastic surgeons, and medspas, and also offers proprietary skincare products (including an autologous PRP-based line) and post-treatment kits as recurring consumables.
Product overview
Aesthetics BioMedical is a medical device company offering a portfolio of aesthetic treatment technologies centered around RF microneedling. The core platform includes UltraVision™ and Vivace Ultra™ (the FDA-cleared next-generation device) which combine ultrasound-assisted visualization with uniform radiofrequency microneedling delivery for personalized skin treatments. Supporting products include CryoTouch MD for pre-treatment numbing, SoME® Skincare for autologous PRP-based at-home care, and the Vivace Experience Kit® with Soothe Mask and Boost Serum for post-treatment recovery. Additional RF devices include Reverso RF and Elite NS for broader aesthetic applications.
Differentiator
Problem solved
Functional benefit
Brands
- UltraVision: Industry-first ultrasound-assisted RF microneedling technology combining ultrasound visualization with radiofrequency energy delivery for personalized aesthetic treatments.
- Vivace
- SoME Skincare
- Reverso RF
- Elite NS
- CryoTouch MD
- Vivace Experience
Quantifiable outcome
- 95% of patients noticed an improvement in skin texture after 2-6 treatment sessions
- +2 more outcomes
Companies that use Aesthetics BioMedical
Customer profileNamed customers8 records
Segments2 records
Aesthetics BioMedical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature8 records
Aesthetics BioMedical partnerships and signals
Strategic signalScale indicators4 records
Recent moves5 records
Expansion highlights5 records
Aesthetics BioMedical competitors and assessment
Company assessmentDirect peers
- Cutera: Aesthetic device maker whose Secret RF is a direct competitor in the RF microneedling category. Competes for the same practice accounts and has similar consumables/handpiece revenue economics.
- InMode: Public medical aesthetic device company whose Morpheus8 is the dominant RF microneedling platform. Directly competes with Aesthetics BioMedical across the same dermatologist, plastic surgeon, and medspa channels, and represents the benchmark competitor in the category.
- Lutronic: Offers the Genius RF microneedling platform positioned on real-time impedance monitoring and precision energy delivery. Competes head-to-head with UltraVision for aesthetic practices.
- Crown Aesthetics (Crown Laboratories): Acquired the SkinPen microneedling franchise and operates in the same in-office aesthetic category, selling devices and consumables to dermatology and medspa channels alongside skincare lines.
- Cynosure (Hologic): Sells the Potenza RF microneedling system alongside a broader aesthetic laser portfolio. Targets the same practices and patient indications (skin rejuvenation, acne scarring) with a comparable consumables-and-device business model.
Broad incumbents
- BTL Aesthetics: Manufacturer of Emface, Emsculpt, and Exion devices — a broader incumbent in physician-dispensed aesthetic technologies. Overlaps in providers and patient demographics rather than device modality.
- Solta Medical (Bausch Health): Established aesthetic energy-based device company (Thermage, Fraxel, Clear+Brilliant) serving the same practices with a broader non-RF-microneedling portfolio. Not a direct device competitor to UltraVision but competes for the same provider's capital budget and patient visits.
- Sciton: Privately-held aesthetic and medical laser company with a broad energy-based device portfolio. Competes for the same high-end dermatology and plastic surgery practices with overlapping patient indications.
- Candela Corporation: Large aesthetic device company offering laser, IPL, and RF platforms to dermatology and medspa channels. Represents a broad incumbent peer with overlapping end-markets but primarily non-microneedling technology focus.
Emerging players
- Venus Concept: Sells multi-application platforms (Venus Viva, Venus Versa) including RF microneedling indications. Closely comparable mid-sized aesthetic device peer with a subscription/leasing commercial model that aligns with Aesthetics BioMedical's DART-financed approach.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Aesthetics BioMedical social profiles
Digital presenceAesthetics BioMedical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Aesthetics BioMedical leadership team
Management profileNumber of profiles
Aesthetics BioMedical funding detail
Funding detailFunding overview
Funding rounds2 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Aesthetics BioMedical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Aesthetics BioMedical
What does Aesthetics BioMedical do?
Aesthetics BioMedical develops and manufactures FDA-cleared aesthetic medical devices, centered on its proprietary combination of ultrasound imaging and uniform radiofrequency (RF) microneedling technology. The company sells these devices directly to medical aesthetic practices, dermatology clinics, plastic surgeons, and medspas, and also offers proprietary skincare products (including an autologous PRP-based line) and post-treatment kits as recurring consumables.
Is Aesthetics BioMedical a public or private company?
Aesthetics BioMedical is a private company. It is currently operating.
When was Aesthetics BioMedical founded?
Aesthetics BioMedical was founded in 2016. It employs 11 to 50 people.
Where is Aesthetics BioMedical based?
Aesthetics BioMedical is headquartered in Phoenix, United States, in the North America region.
How does Aesthetics BioMedical make money?
Three revenue lines are on record. Medical Device Sales are the primary driver. The others are consumable Products and skincare Products.
Who are Aesthetics BioMedical's main competitors?
Direct peers on record are Cutera, InMode, Lutronic, Crown Aesthetics (Crown Laboratories) and Cynosure (Hologic). Broad incumbents are BTL Aesthetics, Solta Medical (Bausch Health), Sciton and Candela Corporation. Venus Concept is listed as an emerging player.
Does Aesthetics BioMedical have an API?
No public API is recorded for Aesthetics BioMedical.
What industry is Aesthetics BioMedical in?
Aesthetics BioMedical's product category is Aesthetic Medical Devices. Its primary akta.pro industry code is CRABAAAJ, Skincare Devices & Beauty Tech (LED, Microcurrent, Cleansing Devices), with a secondary code of CRABAAAF, Dermocosmetics & Medical-Grade Skincare. Its NAICS code is 334510 and its SIC code is 3845.